Abstract
The effects of tumor necrosis factor (TNF) and interleukin-1 (IL-1) on infection with murine cytomegalovirus (MCMV) were investigatedin vitro andin vivo. The addition of each of these cytokines (at 1 ng/ml) to tissue culture monolayers 24 hr prior to MCMV challenge produced a reproducible decrease in vital titer (from 1 × 108 pfu to approximately 4 × 106 pfu for both cytokines). There was no further increase in this effect when a 10 or 100 ng/ml of each of these cytokines was employed. Despite thesein vitro effects, the pretreatment of suckling, weanling, or adult mice with 80 or 400 ng of TNF or IL-1 alone, or 80 ng of each cytokine together, had no effect on the survival of mice following MCMV. Similarly, neither of these cytokines adversely influenced the protective effects of hyperimmune anti-MCMV antiserum; that is, they did not attenuate the protection conferred by the antiserum nor affect the protective effects of subtherapeutic doses of the antiserum. We conclude that despite promising antiviral effects against MCMVin vitro, these agents do not result in a useful therapeutic effectin vivo. Moreover, despite the ability of IL-1 to induce ACTH and corticosterone in mice, IL-1 treatment did not increase the mortality to CMV.
Similar content being viewed by others
References
Dinarello CA. 1988. Interleukin-1. FASEB Journal 2(2): 108–15.
Beutler B, Cerami A. 1987. Cachectin; more than a tumor necrosis factor. New Engl J Med 316: 379–85.
Van der Meer JWM, Barza M, Wolff SM, Dinarello CA. 1988. Low dose recombinant interleukin-1 protects granulocytopenic mice from lethal gram-negative infection. Proc Natl Acad Sci USA 85: 1620–3.
Van't Wout JW, van der Meer JWM, Barza M, Dinarello CA. Protection of neutorpenic mice from lethalCandida albicans infection by recombinant interleukin-1. Eur J Immunol 18: 1143–46
Ozaki Y, Ohashi T, Minami A, Nakamura SI. 1987. Enhanced resistance of mice to bacterial infection induced by recombinant human interleukin-la. Infect Immun 55: 1436–40.
Van der Meer JWM. 1988. The effects of recombinant interleukin-1 and recombinant necrosis factor on non-specific resistance to infection. Biotherapy 1: 19–25.
Parant M, Parant F, Vinit MA, Chedid L. 1987. Action protectrice du “tumor necrosis factor” (TNF) obtenu par recombinaison genetique conter l'infection experimentale bacterienne ou fongique. C. R. Acad Sc Paris 304: III, 1–4.
Wong GHW, Goeddel DV. 1986. Tumor necrosis factors alpha and beta inhibit virus replication and synergise with interferons. Nature, 323: 819–22.
Mestan J, Digel W. Mittnacht S, Hillen H, Blohm D, Moller A, Jacobsen H, Kirchner H. 1986. Antiviral effects of recombinant tumor necrosis factor in vitro. Nature 323: 816–19.
Koff WC, Fann AV. 1986. Human tumor necrosis factor alpha kills herpesvirus infected but not normal cells. Lymphokine res 5: 215–21.
Ito M, O'Malley JA. 1987. Antiviral effects of recombinant human tumor necrosis factor. Lymphokine res 6: 309–18.
Wong GH, Krowka JF, Stites DP, Goeddel DV. 1988. In vitro anti human immunodeficiency virus activities of tumor necrosis factor alpha and interferon gamma. J Immunol 140: 120–4, 1988.
Bielefeldt-Obmann H, Babiuk LA. 1988. Influence of interferons alpha and gamma and of tumor necrosis factor on persistent infection with bovine viral diarrhoea virus in vitro. J Gen Virol 69: 1399–1403.
Arakawa T, Hsu YR, Toth E, Stebbing N. 1987. The antiviral activity of human tumor necrosis factor alpha. J Interferon Res 7: 103–5.
Van Damme J, De Ley M, Van Snick J, Dinarello CA, Billiau A. 1987. The role of interferon-B1 and the 26-kDa protein (interferon-B2) as mediators of the antiviral effect of interleukin 1 and tumor necrosis factor. J Immunol 139: 1867–72.
Rubin RH. 1988. Infection in the renal and liver transplant patient. p. 559–621. In, Rubin RH, Young LS (eds): Clinical Approach to Infection in the Compromised Host. 2nd edition. Plenum Medical Book Co, New York.
Rubin RH, Wilson EJ, Barrett LV, Medearis DN. 1984. Primary cytomegalovirus infection following cardiac transplanation in a murine model. Transplanation 37: 306–10.
Selgrade MK, Osborne JE. 1974. Role of macrophages in resistance to murine cytomegalovirus. Infect Immunity 10: 1383–90.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
van der Meer, J.W.M., Rubin, R.H., Pasternack, M. et al. Thein vivo andin vitro effects of interleukin-1 and tumor necrosis factor on murine cytomegalovirus infection. Biotherapy 1, 227–231 (1989). https://doi.org/10.1007/BF02170891
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02170891